AI Pulse by Inblix

Topic: drug-development

4 articles

Explore our coverage of drug-development — 4 curated articles, summaries, and related resources from the Inblix archive.

Montana’s $12,500 fast track for unproven drugs is now open for business — Inblix summary
Research

Montana’s $12,500 fast track for unproven drugs is now open for business

MIT Technology Review · Jul 31, 2026 · 2 min read

If you’ve got a biotech startup, a drug that’s cleared Phase 1 safety testing in maybe a dozen people, and $12,500, Mon...

A toddler's brain is running out of time. Montana's new law offers a last shot. — Inblix summary
Research

A toddler's brain is running out of time. Montana's new law offers a last shot.

MIT Technology Review · Jul 31, 2026 · 2 min read

Kris DeVault is watching his son Brody miss the most critical years of brain development. At three years old, Brody has...

Moderna's 750 Custom GPTs Are Redesigning Drug Development — Inblix summary
Product

Moderna's 750 Custom GPTs Are Redesigning Drug Development

OpenAI Blog · Jul 17, 2026 · 2 min read

Two months. Seven hundred and fifty custom GPTs. Moderna's partnership with OpenAI isn't a press release gimmick—it's a...

Genmab's 'AI Everywhere' Push Now Saves Staff 3.5 Hours a Week — Inblix summary
Product

Genmab's 'AI Everywhere' Push Now Saves Staff 3.5 Hours a Week

OpenAI Blog · Jul 16, 2026 · 3 min read

Genmab isn't dabbling in AI — the Danish biotech has gone all-in, scaling ChatGPT Enterprise from a 1,000-employee pilo...